Methods Associated With Tumor Burden for Assessing Response to a Cell Therapy
Copyright © Targeted News Service 2024
2024-12-17
ALEXANDRIA, Virginia, Dec. 17 -- JUNO THERAPEUTICS, INC., Seattle, Washington has been assigned a patent (No. US 12168027 B2, initially filed Dec. 16, 2022) developed by three inventors Tina Albertson, Seattle, Washington; Jacob Randolph Garcia, Seattle, Washington; and He Li, Seattle, Washington, for "Methods associated with tumor burden for assessing response to a cell therapy." . . .